WGRX
Wellgistics Health, Inc.
Price Chart
Latest Quote
$0.33
Current Price| Previous Close | $0.36 |
| Open | $0.37 |
| Day High | $0.37 |
| Day Low | $0.32 |
| Volume | 600,301 |
Stock Information
| Shares Outstanding | 102.12M |
| Total Debt | $25.97M |
| Cash Equivalents | $4.23M |
| Revenue | $34.08M |
| Net Income | $-77.75M |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Market Cap | $34.08M |
| EPS (TTM) | $-1.28 |
| Exchange | NCM |
đ Custom Metrics & Score
Score: 0/42| Debt to Equity | 3.73 |
| Debt to Earnings | 14.21 |
| Current Ratio | 0.40 |
| Quick Ratio | 0.13 |
| Avg Revenue Growth | -14.90% |
| Profit Margin | -37.82% |
| Return on Equity | -101.81% |
| FCF Yield | -4.70% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $0.33 | 604,600 |
| 2026-01-30 | $0.36 | 284,600 |
| 2026-01-29 | $0.34 | 712,000 |
| 2026-01-28 | $0.38 | 229,400 |
| 2026-01-27 | $0.39 | 374,100 |
| 2026-01-26 | $0.38 | 418,200 |
| 2026-01-23 | $0.40 | 145,800 |
| 2026-01-22 | $0.41 | 313,800 |
| 2026-01-21 | $0.40 | 234,500 |
| 2026-01-20 | $0.39 | 223,000 |
| 2026-01-16 | $0.41 | 295,700 |
| 2026-01-15 | $0.41 | 216,700 |
| 2026-01-14 | $0.42 | 154,600 |
| 2026-01-13 | $0.42 | 301,100 |
| 2026-01-12 | $0.43 | 569,000 |
| 2026-01-09 | $0.39 | 458,800 |
| 2026-01-08 | $0.40 | 517,200 |
| 2026-01-07 | $0.41 | 424,000 |
| 2026-01-06 | $0.42 | 170,600 |
| 2026-01-05 | $0.41 | 261,400 |
About Wellgistics Health, Inc.
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
đ° Latest News
Wellgistics Health provides corporate outlook for 2026
TipRanks âĸ 2026-01-08T12:46:56Z
Could Blockchain Integration Signal a New Competitive Edge for Wellgistics Health (WGRX)?
Simply Wall St. âĸ 2025-10-26T23:10:02Z
BC-Most Active Stocks
Associated Press Finance âĸ 2025-10-24T14:30:17ZXRP Ledger Used by Nasdaq-Listed Pharma Distributor to Power Payment System for Pharmacies
CoinDesk âĸ 2025-08-16T11:00:44Z
Healthcare firm banks on SEC and Ripple settlement
TheStreet âĸ 2025-05-09T23:29:38Z
Florida Pharma Firm Will Use XRP for Real-Time Payments in $50M Financing Deal
CoinDesk âĸ 2025-05-09T07:26:08Z
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Reconciled Cost Of Revenue | $16,361,517 | $0 | $27,028,874 |
| Cost Of Revenue | $16,361,517 | $0 | $27,028,874 |
| Total Revenue | $18,128,831 | $0 | $32,777,728 |
| Operating Revenue | $18,128,831 | $0 | $32,777,728 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Interest Expense | $831,467 | $15,081 | $287,183 |
| Total Expenses | $24,273,963 | $2,880,603 | $36,200,457 |
| Other Income Expense | $120,373 | $98,132 | $966,112 |
| Other Non Operating Income Expenses | $120,373 | $180,461 | $-851,942 |
| Net Non Operating Interest Income Expense | $-831,467 | $-15,081 | $-287,183 |
| Interest Expense Non Operating | $831,467 | $15,081 | $287,183 |
| Operating Expense | $7,912,446 | $2,880,603 | $9,171,583 |
| General And Administrative Expense | $6,797,782 | $2,880,603 | $7,082,600 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-6,856,226 | $-2,895,684 | $-2,743,800 |
| Net Interest Income | $-831,467 | $-15,081 | $-287,183 |
| Normalized Income | $-6,856,226 | $-2,895,684 | $-4,561,854 |
| Net Income From Continuing And Discontinued Operation | $-6,856,226 | $-2,895,684 | $-2,743,800 |
| Total Operating Income As Reported | $-6,145,132 | $-2,880,603 | $-3,422,729 |
| Net Income Common Stockholders | $-6,856,226 | $-2,895,684 | $-2,743,800 |
| Net Income | $-6,856,226 | $-2,895,684 | $-2,743,800 |
| Net Income Including Noncontrolling Interests | $-6,856,226 | $-2,895,684 | $-2,743,800 |
| Net Income Continuous Operations | $-6,856,226 | $-2,895,684 | $-2,743,800 |
| Pretax Income | $-6,856,226 | $-2,895,684 | $-2,743,800 |
| Operating Income | $-6,145,132 | $-2,880,603 | $-3,422,729 |
| Depreciation Amortization Depletion Income Statement | $1,114,664 | $0 | $2,087,583 |
| Depreciation And Amortization In Income Statement | $1,114,664 | $0 | $2,087,583 |
| Gross Profit | $1,767,314 | $0 | $5,748,854 |
| Earnings From Equity Interest | - | $-82,329 | - |
| Special Income Charges | - | - | $1,818,054 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Diluted EPS | $-0.15 | $-0.06 | $-0.06 |
| Basic EPS | $-0.15 | $-0.06 | $-0.06 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-4,910,095 | $-2,880,603 | $-2,187,088 |
| Reconciled Depreciation | $1,114,664 | $0 | $2,087,583 |
| EBITDA (Bullshit earnings) | $-4,910,095 | $-2,880,603 | $-369,034 |
| EBIT | $-6,024,759 | $-2,880,603 | $-2,456,617 |
| Diluted Average Shares | $47,252,081 | $44,720,000 | $47,252,081 |
| Basic Average Shares | $47,252,081 | $44,720,000 | $47,252,081 |
| Diluted NI Availto Com Stockholders | $-6,856,226 | $-2,895,684 | $-2,743,800 |
| Tax Provision | $0 | $0 | $0 |
| Selling General And Administration | $6,797,782 | $2,880,603 | $7,082,600 |
| Other Gand A | $6,797,782 | $2,880,603 | $7,082,600 |
| Research And Development | - | $375 | $1,400 |
| Total Unusual Items | - | - | $1,818,054 |
| Total Unusual Items Excluding Goodwill | - | - | $1,818,054 |
| Other Special Charges | - | - | $-1,818,054 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Net Tangible Assets | $-31,849,509 | $-2,900,434 | $-5,250 |
| Total Assets | $57,332,650 | $338,364 | $0 |
| Total Non Current Assets | $42,163,982 | $0 | $0 |
| Other Non Current Assets | $1,421,269 | - | - |
| Non Current Prepaid Assets | $85,008 | $0 | - |
| Non Current Note Receivables | $139,771 | $0 | - |
| Goodwill And Other Intangible Assets | $38,583,955 | $0 | - |
| Other Intangible Assets | $22,364,026 | - | - |
| Current Assets | $15,168,668 | $338,364 | $0 |
| Other Current Assets | $1 | - | - |
| Current Deferred Assets | $875,385 | $0 | - |
| Prepaid Assets | $524 | $0 | - |
| Inventory | $9,518,608 | $0 | - |
| Receivables | $3,745,814 | $337,000 | $0 |
| Accounts Receivable | $2,724,814 | $0 | - |
| Allowance For Doubtful Accounts Receivable | $-940,596 | $0 | - |
| Gross Accounts Receivable | $3,665,410 | $0 | - |
| Cash Cash Equivalents And Short Term Investments | $1,028,336 | $1,364 | $0 |
| Cash And Cash Equivalents | $1,028,336 | $1,364 | $0 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Net Debt | $22,464,766 | $348,636 | - |
| Total Debt | $25,108,964 | $350,000 | - |
| Long Term Debt And Capital Lease Obligation | $12,551,457 | $350,000 | - |
| Long Term Debt | $11,455,085 | $350,000 | - |
| Current Debt And Capital Lease Obligation | $12,557,507 | $350,000 | - |
| Current Debt | $12,038,017 | $350,000 | - |
| Other Current Borrowings | $11,927,816 | $250,000 | - |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Total Liabilities Net Minority Interest | $50,598,204 | $3,238,798 | $5,250 |
| Total Non Current Liabilities Net Minority Interest | $12,551,457 | $350,000 | $0 |
| Current Liabilities | $38,046,747 | $2,888,798 | $5,250 |
| Current Deferred Liabilities | $245,765 | $0 | - |
| Payables And Accrued Expenses | $22,131,005 | $1,588,798 | $5,250 |
| Interest Payable | $504,152 | $2,333 | $0 |
| Payables | $21,279,024 | $1,106,465 | $5,250 |
| Other Payable | $10,000,000 | - | - |
| Accounts Payable | $6,334,254 | $1,038,672 | $5,250 |
| Current Notes Payable | - | $100,000 | $0 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Common Stock Equity | $6,734,446 | $-2,900,434 | $-5,250 |
| Total Equity Gross Minority Interest | $6,734,446 | $-2,900,434 | $-5,250 |
| Stockholders Equity | $6,734,446 | $-2,900,434 | $-5,250 |
| Retained Earnings | $-9,757,160 | $-2,900,934 | $-5,250 |
| Long Term Equity Investment | $17,671 | $0 | - |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Ordinary Shares Number | $51,944,397 | $51,944,397 | $51,944,397 |
| Share Issued | $51,944,397 | $51,944,397 | $51,944,397 |
| Tangible Book Value | $-31,849,509 | $-2,900,434 | $-5,250 |
| Invested Capital | $30,227,548 | $-2,550,434 | $-5,250 |
| Working Capital | $-22,878,079 | $-2,550,434 | $-5,250 |
| Capital Lease Obligations | $1,615,862 | $0 | - |
| Total Capitalization | $18,189,531 | $-2,550,434 | $-5,250 |
| Additional Paid In Capital | $16,486,501 | $-3,972 | - |
| Capital Stock | $5,105 | $4,472 | $0 |
| Common Stock | $5,105 | $4,472 | $0 |
| Long Term Capital Lease Obligation | $1,096,372 | $0 | - |
| Current Deferred Revenue | $245,765 | $0 | - |
| Current Capital Lease Obligation | $519,490 | $0 | - |
| Line Of Credit | $110,201 | $0 | - |
| Pensionand Other Post Retirement Benefit Plans Current | $3,112,470 | $1,300,000 | $0 |
| Current Accrued Expenses | $851,981 | $482,333 | $0 |
| Dueto Related Parties Current | $4,944,770 | $67,793 | $0 |
| Investments And Advances | $17,671 | $0 | - |
| Goodwill | $16,219,929 | $0 | - |
| Net PPE | $1,916,308 | $0 | - |
| Accumulated Depreciation | $-1,119,656 | $0 | - |
| Gross PPE | $3,035,964 | $0 | - |
| Leases | $766,467 | $0 | - |
| Other Properties | $2,117,336 | - | - |
| Machinery Furniture Equipment | $152,161 | $0 | - |
| Properties | $0 | $0 | - |
| Inventories Adjustments Allowances | $-233,601 | $0 | - |
| Other Inventories | $6,717,373 | - | - |
| Finished Goods | $3,034,836 | $0 | - |
| Duefrom Related Parties Current | $1,021,000 | $337,000 | $0 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Free Cash Flow | $-1,602,281 | $-349,136 | $0 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Cash Flow | $-1,224,993 | $-349,136 | $0 |
| Cash Flow From Continuing Operating Activities | $-1,224,993 | $-349,136 | $0 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Capital Expenditure | $-377,288 | - | - |
| Investing Cash Flow | $469,072 | $0 | - |
| Cash Flow From Continuing Investing Activities | $469,072 | $0 | - |
| Net Other Investing Changes | $-85,008 | - | - |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Issuance Of Capital Stock | $10,000 | $500 | $0 |
| Financing Cash Flow | $1,782,893 | $350,500 | $0 |
| Cash Flow From Continuing Financing Activities | $1,782,893 | $350,500 | $0 |
| Net Other Financing Charges | $1,152,190 | - | - |
| Net Common Stock Issuance | $10,000 | $500 | $0 |
| Common Stock Issuance | $10,000 | $500 | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Repayment Of Debt | $-135,777 | $0 | - |
| Issuance Of Debt | $756,480 | $350,000 | $0 |
| End Cash Position | $1,028,336 | $1,364 | $0 |
| Beginning Cash Position | $1,364 | $0 | $0 |
| Changes In Cash | $1,026,972 | $1,364 | - |
| Net Issuance Payments Of Debt | $620,703 | $350,000 | $0 |
| Net Short Term Debt Issuance | $620,703 | $0 | $0 |
| Short Term Debt Payments | $-135,777 | $0 | - |
| Short Term Debt Issuance | $756,480 | $0 | $0 |
| Net Long Term Debt Issuance | $0 | $350,000 | - |
| Long Term Debt Issuance | $0 | $350,000 | - |
| Net Business Purchase And Sale | $931,368 | $0 | - |
| Sale Of Business | $931,368 | $0 | - |
| Net Intangibles Purchase And Sale | $-377,288 | $0 | - |
| Purchase Of Intangibles | $-377,288 | $0 | - |
| Change In Working Capital | $3,342,085 | $2,546,548 | $5,250 |
| Change In Other Working Capital | $3,326,274 | $-269,207 | - |
| Change In Other Current Liabilities | $22,091 | $0 | - |
| Change In Other Current Assets | $-587,539 | $0 | - |
| Change In Payables And Accrued Expense | $682,261 | $2,815,755 | $5,250 |
| Change In Accrued Expense | $1,564,576 | $1,782,333 | $0 |
| Change In Payable | $-882,315 | $1,033,422 | $5,250 |
| Change In Account Payable | $-882,315 | $1,033,422 | $5,250 |
| Change In Prepaid Assets | $11,435 | $0 | - |
| Change In Inventory | $-72,356 | $0 | - |
| Change In Receivables | $-40,081 | $0 | - |
| Changes In Account Receivables | $-40,081 | $0 | - |
| Stock Based Compensation | $1,081,106 | $0 | - |
| Asset Impairment Charge | $93,378 | $0 | - |
| Depreciation Amortization Depletion | $1,114,664 | $0 | - |
| Depreciation And Amortization | $1,114,664 | $0 | - |
| Amortization Cash Flow | $1,047,048 | $0 | - |
| Amortization Of Intangibles | $1,047,048 | $0 | - |
| Depreciation | $67,616 | $0 | - |
| Net Income From Continuing Operations | $-6,856,226 | $-2,895,684 | $-5,250 |